Sernova (XTER:PSH) Net Change in Cash : C$-15.99 Mil (TTM As of Jan. 2024)

View and export this data going back to 2021. Start your Free Trial

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Sernova's Net Change in Cash for the three months ended in Jan. 2024 was C$-2.21 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Jan. 2024 was C$-15.99 Mil.

Sernova Net Change in Cash Historical Data

The historical data trend for Sernova's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sernova Annual Data

Trend

Oct14

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Net Change in Cash

Get a 7-Day Free Trial

0.06

2.15

23.92

-24.10

4.95

Sernova Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Net Change in Cash	Get a 7-Day Free Trial															18.72	-9.81	5.10	-9.06	-2.21

Sernova Net Change in Cash Calculation

Sernova's Net Change in Cash for the fiscal year that ended in Oct. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-30.339	+	34.781	+	0.503	+	0
	=	4.95

Sernova's Net Change in Cash for the quarter that ended in Jan. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -4.248 + 2.079 + -0.043 + 0

= -2.21

Net Change in Cash for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-15.99 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sernova Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Sernova's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Sernova (XTER:PSH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sernova Corp (XTER:PSH) » Definitions » Net Change in Cash

Comparable Companies

TSX:EPRX TSXV:ARCH TSXV:NGEN TSX:MDNA TSX:ONC TSX:TH XCNQ:ACOG XCNQ:METX XCNQ:DTC TSX:BCT OCSE:NOVO B VRTX REGN ASX:CSL XKRX:207940 MRNA XKRX:068270 XBRU:ARGX XBRU:UCB BNTX

Traded in Other Exchanges

SEOVF:USA PSH:Germany SVA:Canada

Address

700 Collip Circle, The Stiller Centre, Suite 114, London, ON, CAN, N6G 4X8

Website

https://www.sernova.com

Sernova Corp is a clinical-stage company developing products for the treatment of chronic debilitating diseases. The company is engaged in the research and development of its proprietary Cell Pouch and associated technologies including immune-protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells, which then release proteins and or hormones for the long-term treatment of multiple serious, chronic diseases such as diabetes, hemophilia, and thyroid disease.

Sernova (XTER:PSH) Headlines